Dolby Laboratories (DLB) EBT Margin (2009 - 2026)

Dolby Laboratories' EBT Margin history runs 18 years deep, the most recent figure standing at 30.26% for Q1 2026.

• Quarterly EBT Margin fell 228.0% year-over-year to 30.26% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 21.14% (down 282.0% YoY) and the FY2025 annual result came in at 22.49%, down 204.0% from the prior year.
• EBT Margin was 30.26% for Q1 2026 at Dolby Laboratories, up from 20.65% in the prior quarter.
• Across five years, EBT Margin topped out at 33.4% in Q1 2024 and bottomed at 3.11% in Q3 2023.
• A 5-year average of 20.47% and a median of 19.6% in 2024 frame the typical range for EBT Margin.
• Annual changes were most pronounced in 2022 — EBT Margin plunged 1372 bps — and 2023, when it jumped 1821 bps.
• Dolby Laboratories' EBT Margin stood at 29.85% in 2022, then dropped by 14 bps to 25.61% in 2023, then retreated by 6 bps to 24.1% in 2024, then declined by 14 bps to 20.65% in 2025, then soared by 46 bps to 30.26% in 2026.
• Business Quant data shows DLB's EBT Margin at 30.26% in Q1 2026, 20.65% in Q4 2025, and 13.57% in Q3 2025.